Owner University of Maryland, Baltimore

Inventors Lentz, Kimberley A.; Coop, Andrew; Polli, James E.; Maeda, Dean Y.

Agent Davies Collison Cave

Pub. Number AU-B-2001253226

PCT Pub. Number WO01/76531

Priority 60195854 07.04.00 US; 60269906 21.02.01 US

Filing date 6 April 2001

Wipo publication date 23 October 2001

Acceptance publication date 8 June 2006

A61K 35/50 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/522 (2006.01)

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

A61K 39/42 (2006.01) Medicinal preparations containing antigens or antibodies - viral

A61K 39/44 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen